MedPath

Biobank for development of screening markers for colorectal neoplasia. Translational research in colorectal cancer and adenomas.

Recruiting
Conditions
Coloncancer. Large polyps.
10017990
Registration Number
NL-OMON37786
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
3500
Inclusion Criteria

All subjects 40 years of age or older scheduled for colonoscopy will be invited to participate. Subjects with colorectalcancer (CRC) or advanced adenomas detected at colonoscopy will be included as cases, whereas subjects without advanced neoplasia will be included as controls.
All subjects should be capable to give informed consent. All subjects should speak and understand the Dutch language

Exclusion Criteria

- Subjects < 40 years of age
- No informed consent
- Subjects with IBD/sigmoidoscopy or colonoscopy in the past four weeks/extended hemicolectomie/colostomy
- Subjects who received chemotherapy in the past three weeks
- Hospitalized individuals

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Collection of faeces for development and improvement of new biomarkers for CRC.<br /><br>Development of a stool test with a (panel of) molecular marker(s).<br /><br>Endpoints for evaluation of screening markers: presence of CRC and advanced<br /><br>adenomas (advanced neoplasia).<br /><br><br /><br>The following test characteristics are used as primary outcome measurements for<br /><br>the different biomarkers.<br /><br>- Sensitivity<br /><br>- Specificity<br /><br>- Positive predictive value (PPV)<br /><br>- Negative predictive value (NPV)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Quality and stability of samples collected.</p><br>
© Copyright 2025. All Rights Reserved by MedPath